 |
Publisher: Peytchinski, Gospodin Iliev
ISSN: 1312 773X (Online)
Issue: 2015, vol. 21, issue 2
Subject Area: Medicine - Orthopedics and Traumatology
Pages: 797-800
DOI: 10.5272/jimab.2015212.797
Published online: 26 June 2015
J of IMAB 2015 Apr-Jun;21(2):797-800
CLINICAL RESULTS FROM THE TREATMENT OF CHRONIC SKIN WOUNDS WITH PLATELET RICH PLASMA (PRP).
Pencho Kossev 
, Tsvetan Sokolov.
Department of Orthopedics and Traumatology, MHAT Ruse, Bulgaria.
ABSTRACT:
PURPOSE: To show platelet rich plasma (PRP) application of chronic skin wounds and to evaluate the results from the treatment.
MATERIAL AND METHODS: A total of 14 patients with problematic skin wounds had been treated at the clinic for a period of five years (from May 2009 to December 2014) with the following patient sex ratio: male patients - 5 and female patients - 9. Average age - 48,5 (30-76). Patients with Type 2 Diabetes - 4, with decubitus ulcers - 6, traumatic - 8, with infection - 5. Based on a scheme developed by us, all cases were treated by administering platelet-rich plasma, derived by PRGF Endoret system. Follow-up period was within 4 - 6 months (4,5 on average).
RESULTS: The results have been evaluated based on the following functional scoring systems - Total wound score, Total anatomic score and Total score (20). The baseline values at the very beginning of the follow-up period were as follows: Total wound score - 12 p.; Total anatomic score - 10 p., Total score - 17 p. By the end of the treatment period the score was 0 p., which means excellent results, i.e. complete healing of the wounds.
CONCLUSION: We believe that the application of PRP may become optimal therapy in the treatment of difficult to heal wounds around joints, bone, subject tendons, plantar surface of the foot, etc., as it opens new perspectives in the field of human tissue regeneration.
Key words: chronic skin wounds, functional scoring systems, platelet rich plasma,
- Download FULL TEXT /PDF 503 KB/
Please cite this article in PubMed Style or AMA (American Medical Association) Style:
Kossev P, Sokolov T. Clinical results from the treatment of chronic skin wounds with platelet rich plasma (PRP). J of IMAB. 2015 Jan-Mar;21(2):797-800.
doi: http://dx.doi.org/10.5272/jimab.2015212.797
Correspondence to: Assoc. Prof. Pencho Kosev, Department of Orthopedics and Traumatology, MHAT Ruse; 2, Nezavisimost str., 7002 Ruse, Bulgaria; E-mail: kosev_pencho@yahoo.com
REFERENCES:
1. Crovetti G, Martinelli G, Issi M, Barone M, Guizzardi M, Campanati B, et al. Platelet gel for healing cutaneous chronic wounds. Transfus Apheres Sci. 2004 Apr;30(2):145-151. [PubMed] [CrossRef]
2. Cancela AM, Lana JF, Annichino-Bizzachi JM, Belangero WD, Luzo AC. Use of Platelet-Rich Plasma (PRP) in Treating Chronic Wounds. In: Lana JF, et al. (eds.), Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer-Verlag Berlin, Heidelberg. 2014; p281-288. [CrossRef]
3. Marx RE. Platelet-rich plasma (PRP): what is PRP and what is not PRP? Implant Dent. 2001 Dec; 10(4):225-228. [PubMed] [CrossRef]
4. Bennett SP, Griffiths GD, Schor AM, Leese GP, Schor SL. Growth factors in the treatment of diabetic foot ulcers. Br J Surg. 2003 Feb;90(2):133–146. [PubMed] [CrossRef]
5. Fu X, Li X, Cheng B, Chen W. Sheng Z. Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years. Wound Repair Regen. 2005 Mar-Apr;13(2):122-130. [PubMed] [CrossRef]
6. Lana JF, Weglein A, Vicente E, Perez AG, Rodrigues AA, Luzo AC, at al. Platelet Rich Plasma and Its Growth Factors: The State of the Art. In: Lana JF, et al. (eds.), Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer-Verlag Berlin, Heidelberg. 2014; p:1-59. [CrossRef]
7. Virchenko O, Aspenberg P. How can one platelet injection after tendon injury lead to a stronger tendon after 4 weeks? Interplay between early regeneration and mechanical stimulation. Acta Orthop. 2006 Oct;77(5):806-812. [PubMed] [CrossRef]
8. Weibrich G, Kleis WKG, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofacial Surg. 2002 Apr;30(2):97-102. [PubMed] [CrossRef]
9. Driver VR, Hanft J, Fylling CP, Beriou JM. A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers. Ostomy Wound Manage. 2006 Jun;52(6):68-74.
10. Tarczynska M, Gaweda K . PRP in the Ambulatory Therapy of Tendinopathy of the Elbow, Knee and Foot. In: Lana JF, et al. (eds.), Platelet-Rich Plasma. Lecture Notes in Bioengineering. Springer-Verlag Berlin, Heidelberg. 2014; p:237-247. [CrossRef]
11. Yuan T, Zhang CQ Tang MJ, Shang-Chun Guo SC, Zeng BF. Autologous platelet-rich plasma enchances healing of chronic wounds. Wounds. 2009 Oct;21(10):138-141.
12. Liu H, Van Dyke TE, El-Sharkawy H, Kantarci A, Hasturk H, Alshahat M. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties. J Periodontol. 2007; 78(4):661–669.
13. Margolis DJ, Kantor J, Santanna J, Strom BL, Berlin JA. Effectiveness of platelet releasate for the treatment of diabetic neuropathic foot ulcers. Diabetes Care. 2001 Mar;24(3):483-488. [PubMed] [CrossRef]
14. Anitua E, Aguirre JJ, Algorta J, Ayerdi E, Cabezas AI, Orive G, et al. Effectiveness of autologous preparation rich in growth factors for the treatment of chronic cutaneous ulcers. J Biomed Mater Res B Appl Biomater. 2008 Feb;84B(2):415-421. [PubMed] [CrossRef]
15. Anitua E, Andia I, Ardanza B, Nurden P, Nurden AT . Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb Haemost. 2004 Jan;91(1):4–15. [PubMed] [CrossRef].
Received: 07 April 2015
Published online: 26 June 2015